The trial has three arms comparing single agent adecatumumab to combination chemotherapy (Folfox: 5-FU/Leucovorin plus Oxaliplatin), and to Folfox followed by adecatumumab. The primary endpoint will be the
Medicis, a specialty pharmaceutical company, and Teva Pharmaceutical Industries, a generic pharmaceutical company, have agreed to terminate all legal disputes between them relating to Solodyn extended release tablets.
Plexxikon, a developer of small molecule pharmaceuticals, has received key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-based Drug Discovery platform. Two of the three recently
Mr Parkinson will replace David Swetlow, vice president of finance and operations, who is leaving Protox to pursue entrepreneurial opportunities. Previously, Mr Parkinson was vice president of finance
With over 20 years of finance experience, Mr Gardner has held various positions of increasing responsibility in finance both in CFO and controllership roles. Mr Gardner has previously
Dr Hemberger is currently a director of Zymogenetics, Chroma, Atani and Zosano Pharma. Previously, she was a director at Marion Merrell Dow, NeXstar Pharmaceuticals, Pharmion, Perrigo, Myogen and
As chief scientific officer, Dr Barnes will be responsible for all scientific affairs including R&D, product development, process engineering and clinical and regulatory affairs. Dr Barnes will also
Unlike other methods of fracture treatment, the IlluminOss photodynamic bone stabilization system is designed to enable the patient to have immediate joint mobility post procedure without the need
According to OrSense, the NBM-200MP system offers for the first time a non-invasive, continuous and accurate measurement of oxygen saturation under all physiological conditions, as well as a
Net loss for the year ended December 31, 2008 was $59.22 million or $2.01 per share, compared to $52.37 million or $2.10 per share for the prior year
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.